Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glargine versus liraglutide in insulin-naive adults with inadequately controlled type 2 diabetes
NL-OMON36367Phase 4Active, not recruiting
- Sponsor
- Sanofi
- Start
- Dec 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Dec 2010; status: active, not recruiting.
02
Drugs
insulin glargineliraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON36367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36367.